top of page
TX.jpg

IN THE STATES

TEXAS

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs and  economic impact data, clinical trial data, and vendor/supplier data from 16 biopharmaceutical companies regarding their business relationships with vendors and the total expenditures paid to vendors in Texas.

TX.png

Economic
Output

$76.5B

Direct Jobs Supported by the Industry

40,957

Total Jobs Supported

249,863

State Total Vendor Relationships

3,600

State Total Vendor Spending

$2,302,558,592

Total Clinical
Trials

1,989

Dollar Amount Invested

$1.55B

Clinical Trial Participants

91,696

Total Economic Impact

$4.61B

bottom of page